What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Diabetes mellitus
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Insulin resistance and Gut flora.
His study in Insulin, Inflammation, Adipose tissue, Glucose tolerance test and Insulin receptor are all subfields of Internal medicine.
His Adipose tissue study incorporates themes from Lipopolysaccharide and CD14.
Endocrinology is closely attributed to Receptor in his work.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Carbohydrate metabolism and Obesity.
He has included themes like Microbial metabolism, Host, Type 2 diabetes and Pharmacology in his Gut flora study.
His most cited work include:
- Metabolic endotoxemia initiates obesity and insulin resistance (3606 citations)
- Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice (2798 citations)
- Host-Gut Microbiota Metabolic Interactions (2369 citations)
What are the main themes of his work throughout his whole career to date?
Rémy Burcelin focuses on Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Gut flora.
His Glucagon-like peptide-1 research extends to the thematically linked field of Internal medicine.
His research combines Inflammation and Endocrinology.
His research in Inflammation intersects with topics in Lipid metabolism and CD14.
His Diabetes mellitus research integrates issues from Enteric nervous system and Vagus nerve.
His biological study spans a wide range of topics, including Microbiome, Type 2 diabetes and Metabolomics.
He most often published in these fields:
- Internal medicine (71.97%)
- Endocrinology (65.69%)
- Diabetes mellitus (33.89%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (71.97%)
- Endocrinology (65.69%)
- Gut flora (39.33%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Endocrinology, Gut flora, Diabetes mellitus and Immunology.
Rémy Burcelin has researched Internal medicine in several fields, including Liraglutide and Gastroenterology.
The concepts of his Endocrinology study are interwoven with issues in Receptor and Bacterial translocation.
The Gut flora study combines topics in areas such as Glucose tolerance test, Immune system, Metabolomics, Glycemic and Metabolic pathway.
Rémy Burcelin works on Diabetes mellitus which deals in particular with Type 2 diabetes.
Rémy Burcelin interconnects Offspring, Lipid metabolism and Insulin resistance in the investigation of issues within Immunology.
Between 2017 and 2021, his most popular works were:
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. (202 citations)
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. (202 citations)
- Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Diabetes mellitus
The scientist’s investigation covers issues in Gut flora, Immunology, Internal medicine, Endocrinology and Diabetes mellitus.
His study in Gut flora is interdisciplinary in nature, drawing from both Metabolic pathway, Secretory IgA and Metabolomics.
As part of the same scientific family, Rémy Burcelin usually focuses on Immunology, concentrating on Lipid metabolism and intersecting with Intestinal permeability, Immune system and Inflammation.
His Internal medicine research is multidisciplinary, relying on both Phenotype, Feces and Lysozyme.
His Endocrinology study combines topics from a wide range of disciplines, such as Taste and Lingual papilla.
His study looks at the relationship between Dysbiosis and fields such as Risk factor, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
